Brief: Trevena Announces Publication Of Results From Special Population Studies For Oliceridine
Nov 20 (Reuters) - Trevena Inc TRVN.O :
* TREVENA ANNOUNCES PUBLICATION OF RESULTS FROM SPECIAL
POPULATION
STUDIES FOR OLICERIDINE
* TREVENA - NO DOSE ADJUSTMENTS REQUIRED FOR PATIENTS WITH
RENAL
IMPAIRMENT/PATIENTS WITH MILD / MODERATE HEPATIC IMPAIRMENT IN
PHARMACOKINETIC STUDIES
Source text for Eikon: ID:nGNX3txNps
Further company coverage: TRVN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trevena
See all newsTrevena Inc reports results for the quarter ended in June - Earnings Summary
Trevena Inc expected to post a loss of 29 cents a share - Earnings Preview
Brief: Trevena Q2 EPS USD -0.23
Brief: Trevena Announces $2M Non-Dilutive Financing Tranche And Reduction In Outstanding Liabilities In Connection With Existing Ex-Us Royalty Financing
U.S. STOCKS ON THE MOVE-Allstate, MicroStrategy, AutoZone